Exercise and Respiratory Therapy in Patients With Rheumatoid Arthritis / Collagenosis and Pulmonary Hypertension
1 other identifier
interventional
45
1 country
1
Brief Summary
In Patients with rheumatic disease exercise training is a well established element of therapy. In contrast patients with severe pulmonary hypertension are advised to avoid physical exertion and must not perform exercise training. This study aims to evaluate the effectivity and safety of a low-dose training program in patients with pulmonary hypertension and rheumatic disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2011
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 25, 2007
CompletedFirst Posted
Study publicly available on registry
June 26, 2007
CompletedStudy Start
First participant enrolled
July 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2023
CompletedJuly 14, 2022
July 1, 2022
12.4 years
June 25, 2007
July 12, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
Change in the 6-minute walking distance
after 3 weeks and after 15 weeks compared to baseline.
Quality of life (SF-36)
baseline and 15 weeks
Secondary Outcomes (6)
change in inflammatory parameters (BKS, CRP, Leucocytes), change in inflammatory cytokines (TNF-α), change in parameters of the vascular endothelium (Endothelin, PDGF, VEGF), and endothelial progenitor cells
baseline and 15 weeks
Physical capacity in the cardiopulmonary exercise testing (Watt)
baseline, 3 weeks, 15 weeks
change of peak oxygen consumption and other parameters of cardiopulmonary exercise testing.
baseline, 3 weeks, 15 weeks
hemodynamic parameters: dimension and pump function of the right and the left ventricle.
baseline, 15 weeks
change in systolic pulmonary arterial pressure at rest and during exercise
baseline, 3 weeks, 15 weeks
- +1 more secondary outcomes
Study Arms (2)
exercise training group
ACTIVE COMPARATORexercise and respiratory therapy with specific program for pulmonary hypertension (respiratory therapy, dumbbell training, ergometer training, mental training)
Control group without exercise training
NO INTERVENTIONcontinuation of sedentary lifestyle without advice for specific exercise training
Interventions
exercise training with specific program (respiratory therapy, dumbbell training, ergometer training, mental training)
Eligibility Criteria
You may qualify if:
- Informed consent
- Men and women 18 - 80 years
- Diagnosed rheumatic disease: rheumatoid arthritis, Collagenosis (Systemic Lupus Erythematodes, Systemic Sclerosis, Sjögren-Syndrome, Sharp-Syndrome, Crest-Syndrome, Mixed connective tissue disease)
- Symptomatic PAH (WHO- functional class II-IV) invasively diagnosed by right heart catheterisation
- Mean pulmonary artery pressure (mPAP) \> 25 mmHg
- Pulmonary capillary wedge pressure (PCWP) \> 15 mmHg
- Pulmonary vascular resistance (PVR) at baseline \>320 dyn.sec/cm5 patients under optimized medical treatment since at least 2 ½ months
You may not qualify if:
- Other forms of PAH.
- Pregnancy or lactation
- Change in medication during the last 2 ½ months
- Patients with signs of right heart decompensation
- Severe impairment of walking
- Unclear diagnosis
- No invasive diagnosis of PH
- Acute illness, infection, fever
- Severe lung disease with FEV1 \<50% and TLC\< 70% below reference
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Thoraxclinic at the University Hospital Heidelberg
Heidelberg, Baden-Wurttemberg, 69126, Germany
Related Publications (1)
Grunig E, Maier F, Ehlken N, Fischer C, Lichtblau M, Blank N, Fiehn C, Stockl F, Prange F, Staehler G, Reichenberger F, Tiede H, Halank M, Seyfarth HJ, Wagner S, Nagel C. Exercise training in pulmonary arterial hypertension associated with connective tissue diseases. Arthritis Res Ther. 2012 Jun 18;14(3):R148. doi: 10.1186/ar3883.
PMID: 22709477DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ekkehard Gruenig, MD
Thoraxclinic at the University Hospital Heidelberg
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Dr. med. Ekkehard Grünig
Study Record Dates
First Submitted
June 25, 2007
First Posted
June 26, 2007
Study Start
July 1, 2011
Primary Completion
December 1, 2023
Study Completion
December 1, 2023
Last Updated
July 14, 2022
Record last verified: 2022-07